|
|
|
Home > Pancreas Education > Symptoms of Pancreatic Cancer > Digestive Difficulties
Digestive Difficulties
In Pancreatic Cancer: Digestive difficulties including indigestion, nausea, weight loss, a poor appetite, and diarrhea, can arise as a result of pressure from a pancreatic cyst or tumor on the stomach or the small intestine that causes a block in the digestive tract. When a tumor grows, it can wrap around the far end of the stomach, causing a partial block. This can cause nausea, vomiting, and pain which may worsen after eating.
Diarrhea results when the nutrients in food are not absorbed properly. When this occurs, stool can become loose, watery, oily and foul-smelling. Pancreatic enzymes are responsible for digesting fatty foods. If a tumor blocks the pancreatic duct, insufficient pancreatic juices in the intestines can lead to poor absorption and diarrhea, as the undigested food passes quickly through the digestive tract. If this happens, stool may float due to the higher fat content, appear bulky, greasy, and unusually pale.
Other Causes: Stomach pain, nausea, vomiting, and diarrhea can be caused by a number of conditions. You should consult your physician if you are experiencing these symptoms. Oily stools can also be caused by autoimmune diseases such as celiac disease, where absorption in the intestines is affected.
|
|
| |
APPOINTMENT CENTER
What to expect from an appointment with a specialist:
Appointment Request Form
Directions to the Center

THE PANCREAS CENTER MAP
Herbert Irving Pavilion, 8th Floor
161 Fort Washington Ave,
New York, NY 10032
OUR SPECIALISTS
Pancreas Center patients have access to a highly experienced, multi-disciplinary team of gastroentorologists, oncologists, surgeons, radiologists, nurse practitioners, geneticists, genetic counselors and nutritionists.
CLINICAL TRIALS
You can play a more active role in your own health care, gain access to innovative therapies before they become widely available, and help others by contributing to advancements in medical research by participating in clinical trials.
|
|
|